Cubist Systematic Strategies LLC Reduces Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)

Cubist Systematic Strategies LLC lessened its position in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 46.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 135,350 shares of the medical instruments supplier's stock after selling 119,184 shares during the quarter. Cubist Systematic Strategies LLC owned about 0.33% of AngioDynamics worth $1,240,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Barclays PLC increased its stake in shares of AngioDynamics by 81.0% in the third quarter. Barclays PLC now owns 83,582 shares of the medical instruments supplier's stock worth $651,000 after acquiring an additional 37,394 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of AngioDynamics by 28.7% in the third quarter. JPMorgan Chase & Co. now owns 553,161 shares of the medical instruments supplier's stock worth $4,304,000 after buying an additional 123,271 shares in the last quarter. Moody National Bank Trust Division lifted its stake in shares of AngioDynamics by 70.2% in the fourth quarter. Moody National Bank Trust Division now owns 55,780 shares of the medical instruments supplier's stock worth $511,000 after buying an additional 23,003 shares in the last quarter. SG Americas Securities LLC increased its position in AngioDynamics by 21.3% during the fourth quarter. SG Americas Securities LLC now owns 16,102 shares of the medical instruments supplier's stock worth $147,000 after purchasing an additional 2,832 shares during the last quarter. Finally, R Squared Ltd acquired a new stake in AngioDynamics during the fourth quarter worth about $49,000. Institutional investors own 89.43% of the company's stock.

AngioDynamics Price Performance

Shares of ANGO stock traded up $0.23 during trading on Friday, reaching $9.40. The company's stock had a trading volume of 211,196 shares, compared to its average volume of 554,762. The company has a market capitalization of $381.71 million, a price-to-earnings ratio of -1.67 and a beta of 0.58. The stock's 50-day moving average price is $9.45 and its 200 day moving average price is $9.39. AngioDynamics, Inc. has a 1-year low of $5.47 and a 1-year high of $13.50.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last announced its quarterly earnings data on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share for the quarter, beating analysts' consensus estimates of ($0.13) by $0.16. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The firm had revenue of $72.00 million during the quarter, compared to analysts' expectations of $70.30 million. The company's revenue for the quarter was down 4.3% compared to the same quarter last year. On average, sell-side analysts anticipate that AngioDynamics, Inc. will post -0.37 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright restated a "buy" rating and set a $16.00 price objective (up from $15.00) on shares of AngioDynamics in a research report on Monday, April 7th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.